Dermatology

Cutaneous medicine, inflammatory skin diseases and clinical dermatology.

Japan rare dermatology review maps nanbyo framework to mechanism-based care

A Japanese nanbyo review links rare skin diseases to mechanism-based therapies, regulatory approvals, and a translational trial framework.

A Frontiers in Immunology study links dihydrokaempferol from Platycladus orientalis leaves to KIT-associated mast cell activity in androgenetic…

In 49 healthy adults, higher palmar lactic acid tracked with less hand scaling and stronger in vitro pathogen…

A PLOS ONE study links pyrethroid exposure to keloid-related molecular changes, with VCAM1 outperforming FGFR1 in validation and…

AbCellera will not advance ABCL575 beyond phase 1 despite favorable tolerability, citing setbacks across the OX40/OX40L class.

Skin-resident CXCR6+ memory CD4+ T cells and dendritic cells form dermal hubs tied to relapse in allergic dermatitis,…

DailyMed labeling for Clindagel details acne efficacy, low systemic absorption, and the need to watch for rare but…

DailyMed label for hydroquinone-based Obagi system details topical bleaching for hyperpigmentation, sun protection requirements, and safety warnings.

DailyMed updated the Obagi Clenziderm acne system label, detailing salicylic acid and benzoyl peroxide use, dosing, storage, and…

A review of Japan’s nanbyo skin disease framework links rare dermatoses to mechanism-based treatments, biomarkers, and trial design.

Dermatology

Cutaneous medicine, inflammatory skin diseases and clinical dermatology.

In Brief The 5-minute rounds